Fosaprepitant and Dacarbazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fosaprepitant (fosaprepitant) and Dacarbazine (dacarbazine). Common drug interactions include platelet count decreased among females and bone marrow failure among males.

The phase IV clinical study analyzes what interactions people have when they take Fosaprepitant and Dacarbazine. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Fosaprepitant?

Fosaprepitant has active ingredients of fosaprepitant. eHealthMe is studying from 1,178 Fosaprepitant users. Check the latest studies of Fosaprepitant.

What is Dacarbazine?

Dacarbazine has active ingredients of dacarbazine. eHealthMe is studying from 8,064 Dacarbazine users. Check the latest studies of Dacarbazine.

On Jul, 25, 2026

14 people who take Fosaprepitant and Dacarbazine together, and have interactions are studied.

Fosaprepitant and Dacarbazine drug interactions.

What are the common drug interactions of Fosaprepitant and Dacarbazine, by gender? *:

female:

Platelet count decreased
Pulmonary toxicity (side effects on the lungs)
Pyrexia (fever)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Alveolitis allergic (inflammation of the alveoli within the lung caused by hypersensitivity to inhaled organic dusts)
Arthralgia (joint pain)
Cough
Duodenitis (inflammation of the duodenum)
Dyspepsia (indigestion)
Febrile neutropenia (fever with reduced white blood cells)

male:

Bone marrow failure
Malaise (a feeling of general discomfort or uneasiness)
Neuropathy peripheral (surface nerve damage)

What are the common drug interactions of Fosaprepitant and Dacarbazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Seizure (abnormal excessive or synchronous neuronal activity in the brain)

20-29:

Dyspepsia (indigestion)
Flushing (the warm, red condition of human skin)
Heart rate decreased
Heart rate increased
Hyperhidrosis (abnormally increased sweating)
Nausea (feeling of having an urge to vomit)
Syncope (loss of consciousness with an inability to maintain postural tone)

30-39:

Diarrhoea
Abdominal pain
Anaemia (lack of blood)
Dehydration (dryness resulting from the removal of water)
Neutropenia (an abnormally low number of neutrophils)
Platelet count decreased
Pyrexia (fever)
Arthralgia (joint pain)
Febrile neutropenia (fever with reduced white blood cells)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)

40-49:

Duodenitis (inflammation of the duodenum)
Gastritis (inflammation of stomach)
Nausea (feeling of having an urge to vomit)
Vomiting
Abdominal pain

50-59:

n/a

60+:

Bone marrow failure
Dyspnoea (difficult or laboured respiration)
Malaise (a feeling of general discomfort or uneasiness)
Neuropathy peripheral (surface nerve damage)
Pulmonary toxicity (side effects on the lungs)
Alveolitis allergic (inflammation of the alveoli within the lung caused by hypersensitivity to inhaled organic dusts)
Cough
Lung disorder (lung disease)
Pneumonia

What are the existing conditions these people have? *

Hodgkin's Lymphoma (cancer originating from white blood cells): 13 people, 92.86%
Nausea (feeling of having an urge to vomit): 4 people, 28.57%
Constipation: 2 people, 14.29%
Stress And Anxiety: 1 person, 7.14%
Sleep Disorder: 1 person, 7.14%
Rash Maculo-Papular (red area on the skin that is covered with small confluent bumps): 1 person, 7.14%
Polycystic Ovary Disease (cysts in the ovaries that occurs when the follicle stops developing): 1 person, 7.14%
Indigestion: 1 person, 7.14%
Hodgkin's Disease Mixed Cellularity Stage Unspecified (cancer originating from white blood cells- stage unspecified): 1 person, 7.14%
Headache (pain in head): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Fosaprepitant and Dacarbazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously